YUWELL
Chinese medical device company
Last updated November 4, 2026
AI crawler reads
2requests
1companies- Anthropic2
- Profile
- 2
- Controversies
- 0
- JSON · MD
- 0
- First read
- Nov 4, 2026
- Latest read
- Nov 4, 2026
From this site's server log
History
Yuwell Medical was established in 1998 in Jiangsu, China, under the corporate name Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. The company emerged during a period when China's healthcare market was developing greater domestic manufacturing capacity and when household medical care was becoming more common. It built its initial identity around accessible medical equipment for home and community use, including respiratory-care devices, monitoring equipment, and other durable products. During its expansion, Yuwell developed a multi-category portfolio rather than remaining limited to one device class. Its products came to cover oxygen concentrators, nebulizers, suction equipment, blood-pressure monitors, thermometers, glucose-monitoring products, rehabilitation devices, and equipment used in hospitals and clinics. This combination allowed the company to serve both institutional purchasers and households. The brand's distribution model also broadened from traditional medical channels to pharmacies, retail networks, distributors, and online sales. Yuwell's corporate development included investment in production, research and development, distribution, and acquisitions. The company listed on the Shenzhen Stock Exchange in 2008 under ticker 002223. The listing gave it access to public capital and increased the transparency requirements applicable to its operations. It also established Yuwell as one of the more visible listed Chinese medical-device companies serving both professional and home-care markets. A significant international step came in 2013, when Yuwell acquired a controlling interest in AirSep Corporation, a U.S. company associated with oxygen-generation and respiratory-care equipment. The transaction expanded Yuwell's international footprint and added technology and product capabilities in respiratory care. Yuwell subsequently continued to present itself as a diversified medical-device business rather than solely as a domestic consumer-health brand. The COVID-19 period brought exceptional attention to oxygen concentrators, ventilatory support, and related equipment. Yuwell's respiratory products became part of the broader discussion about medical-device supply, production capacity, and access to oxygen-support equipment. The period also highlighted the operational risks of rapid demand changes, including component supply, logistics, quality assurance, and regulatory compliance. In its current form, Yuwell is best understood as a broad medical-device platform with a strong home-healthcare identity. Its activities span respiratory therapy, diabetes management, patient monitoring, rehabilitation, and selected clinical equipment. The company continues to operate under the Yuwell/Yuyue brand while using a combination of domestic manufacturing, professional distribution, retail channels, and international business to reach customers.
- 2020
Pandemic-era respiratory-care demand
[1]COVID-19 increased demand and public attention for oxygen concentrators and respiratory-support equipment, including products in Yuwell's portfolio.
- 2013
AirSep investment and acquisition
[3]Yuwell acquired a controlling interest in AirSep Corporation, strengthening its position in oxygen-generation and respiratory-care equipment.
- 2008
Shenzhen Stock Exchange listing
[2]Yuyue Medical became a publicly traded company on the Shenzhen Stock Exchange under ticker 002223.
- 1998
Company established
[1]Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. was established in Jiangsu, China, founding the business that operates the Yuwell medical-device brand.
Products and positioning
A broad Chinese medical-device platform positioned between professional clinical equipment and accessible home healthcare, with particular strength in respiratory care, chronic-disease monitoring, rehabilitation, and durable medical equipment.
Respiratory care
Oxygen concentrators
Yuwell's oxygen concentrators are designed to provide supplemental oxygen by concentrating oxygen from ambient air. They are associated with home respiratory care and are sold in multiple configurations for different usage requirements. The category is one of the brand's most recognizable product areas and connects its consumer-health business with clinical respiratory support.
Respiratory care
Non-invasive ventilation and sleep-respiratory equipment
This category includes equipment used for non-invasive respiratory support and sleep-related breathing management. Products serve a more specialized role than basic home monitoring devices and are relevant to respiratory clinics, hospitals, and patients receiving prescribed home therapy.
Diabetes management
Blood-glucose monitoring systems
Yuwell's diabetes-management portfolio includes blood-glucose meters and related monitoring supplies. These products are intended to support routine measurement and self-management, extending the brand into one of the largest chronic-disease home-care categories.
Patient monitoring
Blood-pressure monitors
Blood-pressure monitors are part of Yuwell's household monitoring range. They are designed for regular measurement outside hospitals and complement the company's diabetes, respiratory, and general home-health products.
Respiratory and patient care
Nebulizers and suction machines
Nebulizers and suction equipment support respiratory treatment and patient care. The products broaden Yuwell's respiratory portfolio beyond oxygen supply and are used across home-care and professional-care environments, subject to the intended product and regulatory designation.
Rehabilitation
Rehabilitation and mobility equipment
Yuwell also markets equipment associated with rehabilitation, mobility, and daily patient support. These products address recovery and longer-term care needs and help position the company as a broader medical-device supplier rather than a respiratory-only specialist.
Brand decisions
2013
Acquisition of a controlling interest in AirSepM&ABackground
Yuwell sought to deepen its respiratory-care and oxygen-generation capabilities and expand internationally.
Action taken
Yuwell acquired a controlling interest in AirSep Corporation, a U.S. respiratory-care equipment business.
Aftermath
The transaction broadened Yuwell's respiratory portfolio and international operating footprint.
2008
Public-market expansionStrategyBackground
Yuwell had expanded beyond a narrow home-care range into a broader medical-device business serving both institutions and households.
Action taken
The company listed on the Shenzhen Stock Exchange, creating a public financing and governance platform for subsequent growth.
Aftermath
The listing increased Yuwell's visibility and disclosure obligations and supported its development as a diversified listed medtech company.
Recent events
Ant Consumer Finance completes RMB 22 billion capital increase[4]
China Cinda announced on December 24, 2021, that Ant Consumer Finance had issued RMB 22 billion in additional registered capital to its subscribers, increasing its registered capital to RMB 30 billion.
Reported
Honeywell UOP and Yuyue sign long-term cooperation agreement[5]
Honeywell UOP and Jiangsu Yuyue Medical Equipment signed a long-term cooperation agreement to work on high-performance molecular sieve solutions for the global oxygen concentrator market.
- Unconfirmed
Reported
Yuwell wins Jiangsu Science and Technology Innovation Development Award[6]
Yuwell received the inaugural Jiangsu Science and Technology Innovation Development Award, which was awarded by the Jiangsu Provincial People's Government.
Reported
Yuwell announces proposed acquisition of a stake in Kailite[7]
Yuwell announced a proposed purchase of a combined 50.993% stake in Kailite from seven parties.
- Unconfirmed
Yuyue Medical revises its first-half 2020 earnings forecast[8]
Yuyue Medical issued a revised forecast for first-half 2020 net profit attributable to shareholders of 1.067–1.12 billion yuan, which it said represented year-on-year growth of 100%–110%.
Reported
Yuyue launches high-flow respiratory humidification therapy device[9]
Yuyue Medical held an online launch event for its high-flow respiratory humidification therapy device.
- Unconfirmed
Yuyue Medical completes acquisition of 95.95% of 66 Vision[10]
Yuyue Medical disclosed that the transfer of 95.95% of 66 Vision’s shares had been completed, making 66 Vision its controlled subsidiary. The source does not specify the date on which the transfer was completed.
Sources10 sources
- 1Yuwell official websiteyuwell.com
- 2Shenzhen Stock Exchangeszse.cn
- 3AirSep transaction filingsec.gov
- 4蚂蚁消金完成220亿元增资finance.jrj.com.cn
- 5霍尼韦尔UOP与鱼跃医疗签署长期合作协议prnasia.com
- 6鱼跃医疗荣获江苏省科技创新发展奖prnasia.com
- 7鱼跃医疗公告拟收购凯立特部分股权finance.sina.com.cn
- 8鱼跃医疗修正2020年上半年业绩预告stock.hexun.com
- 9鱼跃医疗发布高流量呼吸湿化治疗仪prnasia.com
- 10鱼跃医疗完成收购六六视觉95.95%股份sc.stock.cnfol.com
Cite this profile: Cite the canonical profile. /brand-wiki/yuwell · Editorial policy · How profiles are compiled